Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Monitoring Influenza Severity on Tamiflu (MIST)

Trial Profile

Monitoring Influenza Severity on Tamiflu (MIST)

Phase of Trial: Phase III

Latest Information Update: 18 Oct 2018

At a glance

  • Drugs Oseltamivir (Primary)
  • Indications Influenza virus infections
  • Focus Therapeutic Use
  • Acronyms MIST
  • Most Recent Events

    • 07 Dec 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 28 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 28 Feb 2011 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top